Zacks Investment Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$222K	Buy	+887	New	+$221K	﹤0.01%	648
2024 Q2	–	Sell	-782	Closed	-$310K	–	724
2024 Q1	$310K	Sell	782 -8,288	-91%	-$3.07M	﹤0.01%	529
2023 Q4	$3.19M	Sell	9,070 -19,701	-68%	-$6.97M	0.04%	237
2023 Q3	$10.8M	Buy	28,771 +645	+2%	+$249K	0.14%	141
2023 Q2	$10.8M	Buy	+28,126	New	+$10M	0.14%	137
2023 Q1	–	Sell	-20,228	Closed	-$71.2K	–	709
2022 Q4	$71.2K	Buy	+20,228	New	+$4.79M	﹤0.01%	582
2022 Q3	–	Sell	-11,476	Closed	-$3.47M	–	663
2022 Q2	$3.47M	Sell	11,476 -123	-1%	-$40K	0.05%	198
2022 Q1	$4.76M	Sell	11,599 -14,620	-56%	-$5.72M	0.07%	192
2021 Q4	$12.3M	Buy	26,219 +1,223	+5%	+$526K	0.17%	130
2021 Q3	$10.6M	Buy	24,996 +1,337	+6%	+$564K	0.17%	131
2021 Q2	$8.5M	Buy	23,659 +1,122	+5%	+$371K	0.14%	140
2021 Q1	$6.35M	Sell	22,537 -4,682	-17%	-$1.34M	0.11%	156
2020 Q4	$7.71M	Buy	27,219 +1,393	+5%	+$391K	0.14%	132
2020 Q3	$7.1M	Buy	25,826 +6,984	+37%	+$1.85M	0.14%	126
2020 Q2	$4.28M	Buy	+18,842	New	+$3.7M	0.09%	145
2019 Q4	–	Sell	-3,357	Closed	-$476K	–	600
2019 Q3	$476K	Buy	+3,357	New	+$462K	0.01%	445
2016 Q4	–	Sell	-2,748	Closed	-$205K	–	747
2016 Q3	$205K	Sell	2,748 -2,811	-51%	-$223K	0.01%	598
2016 Q2	$422K	Buy	+5,559	New	+$405K	0.01%	460
2014 Q4	–	Sell	-25,826	Closed	-$1.16M	–	761
2014 Q3	$1.16M	Buy	25,826 +1,375	+6%	+$58.4K	0.04%	224
2014 Q2	$1.03M	Sell	24,451 -450	-2%	-$19.3K	0.04%	252
2014 Q1	$1.1M	Sell	24,901 -4,639	-16%	-$218K	0.04%	234
2013 Q4	$1.45M	Sell	29,540 -708	-2%	-$33.1K	0.06%	199
2013 Q3	$1.25M	Sell	30,248 -2,942	-9%	-$112K	0.05%	211
2013 Q2	$1.17M	Buy	+33,190	New	+$1.09M	0.05%	205